NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Genomelink

Genomelink

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://genomelink.io/

Last Round

Series A

Dec 1, 2021

Total Funding Raised

$23.01M

Company Overview

Genomelink is a biotechnology company that operates a personal genomics platform allowing users to upload raw DNA data to access insights on ancestry, wellness, and personality traits.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Freemium, Usage-Based SaaS

AI Layer

Application

Keywords

consumer genomicsdna data analysisdna uploadgenetic testingpersonalized health reportsbioinformaticsancestry explorationwellness optimizationdirect-to-consumerDTCdna kitdna interpretationbiohackingprecision medicinegenetics platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genomelink Comps

Public and private peers based on sector, stage, and business model.

Genomelink comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Genomelink Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 1, 2021
SeedJul 1, 2021
SeedNov 30, 2018
SeedJan 1, 2018
SeedAug 22, 2017

Key People

Founding team and executive leadership

Kensuke Numakura

Co-Founder And CTO

Founding Team

Tomohiro Takano

CEO

Executive Team

Genomelink Investors

Notable investors and investment history

Genomelink Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Genomelink Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Genomelink's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerkeley, California
Employee Range14
Year Founded2017
Last FundingDec 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.